Werewolf Therapeutics, Inc. (NASDAQ:HOWL) combines selective tumor targeting, masking, and validated linker technology with ...
Marc Santos is a Guides Staff Writer from the Philippines. He's a seasoned writer with over four years of industry experience, and he is an enjoyer of all things difficult in gaming. If Marc's not ...
Werewolf Therapeutics is developing a "conditionally activated" interleukin-2 (IL-2) drug for the treatment of stage IV melanoma and metastatic cancers. The drug aims to deliver therapeutic doses of ...
Forbes contributors publish independent expert analyses and insights. News and opinion about video games, television, movies and the internet. It’s the final week of weapon additions for Destiny 2’s ...